A carregar...
Feasibility of a pilot program for COVID‐19 convalescent plasma collection in Wuhan, China
BACKGROUND: A novel coronavirus has caused an international outbreak. Currently, there are no specific therapeutic agents for coronavirus infections. Convalescent plasma (CP) therapy is a potentially effective treatment option. METHODS: Patients who had recovered from COVID‐19 and had been discharge...
Na minha lista:
| Publicado no: | Transfusion |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7300543/ https://ncbi.nlm.nih.gov/pubmed/32491199 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/trf.15921 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|